Celldex Therapeutics | 8-K: Celldex Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Celldex Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Celldex Therapeutics | 8-K: Current report
Celldex Therapeutics | 8-K: Celldex Reports First Quarter 2024 Financial Results and Provides Corporate Update
Celldex Therapeutics | DEF 14A: Definitive information statements
Celldex Therapeutics | 8-K: Current report
Celldex Therapeutics | 8-K: Celldex Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
Celldex Therapeutics | 8-K: Current report
Celldex Therapeutics | 8-K: Current report
Celldex Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Celldex Therapeutics | 8-K: Celldex Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Celldex Therapeutics | 8-K: Celldex Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Celldex Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Celldex Therapeutics | 8-K: Current report
Celldex Therapeutics | 8-K: Celldex Reports First Quarter 2023 Financial Results and Provides Corporate Update
Celldex Therapeutics | DEF 14A: Definitive proxy statements
Celldex Therapeutics | 8-K: Current report
Celldex Therapeutics | 8-K: Celldex Reports Fourth Quarter and Year End 2022 Financial Results and Provides Corporate Update
Celldex Therapeutics | 8-K: Current report
Celldex Therapeutics | 8-K: Celldex Reports Third Quarter 2022 Financial Results and Provides Corporate Update
No Data
No Data